Ecthyma Gangrenosum of the Groin Resistant to Ciprofloxacin, Cefepime, Metronidazole, and Meropenem. What's Next?

Abstract Ecthyma gangrenosum is a cutaneous infection characterized by gangrenous ulcers with erythematous borders. Bacterial invasion of arterial media, adventitia, and veins promotes ischemic necrosis. Pseudomonas aeruginosa is the most frequently identified organism, although other bacterial and fungal pathogens have been implicated. The risk of ecthyma gangrenosum development and infection prolongation is increased among immunocompromised and neutropenic patients. While eradication requires source control and wound closure, neutropenic patients are poor surgical candidates due to low leukocytes and poor graft uptake. Furthermore, a prolonged neutropenic state provides ample access of enteric flora to the broad-spectrum-treated wound, promoting multidrug-resistant strains. Here, we present a fatal case of multidrug-resistant ecthyma gangrenosum in a neutropenic patient with acute myeloid leukemia. We emphasize the importance of leukopenia resolution for recovery, which is often not achieved in prolonged neutropenic patients.

Authors

Institutions

Publication Details

Journal
Infectious Diseases in Clinical Practice
Published
2025-03-28
DOI
https://doi.org/10.1097/ipc.0000000000001444
Primary Topic
Infections and bacterial resistance
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ecthyma Gangrenosum of the Groin Resistant to Ciprofloxacin, Cefepime, Metronidazole, and Meropenem. What's Next?

Nicole Natarelli, Sadaf Aslam, John N. Greene
Infectious Diseases in Clinical Practice
Infections and bacterial resistance
article

Ecthyma Gangrenosum of the Groin Resistant to Ciprofloxacin, Cefepime, Metronidazole, and Meropenem. What's Next?

Nicole Natarelli, Sadaf Aslam, John N. Greene
article en

Abstract

Abstract Ecthyma gangrenosum is a cutaneous infection characterized by gangrenous ulcers with erythematous borders. Bacterial invasion of arterial media, adventitia, and veins promotes ischemic necrosis. Pseudomonas aeruginosa is the most frequently identified organism, although other bacterial and fungal pathogens have been implicated. The risk of ecthyma gangrenosum development and infection prolongation is increased among immunocompromised and neutropenic patients. While eradication requires source control and wound closure, neutropenic patients are poor surgical candidates due to low leukocytes and poor graft uptake. Furthermore, a prolonged neutropenic state provides ample access of enteric flora to the broad-spectrum-treated wound, promoting multidrug-resistant strains. Here, we present a fatal case of multidrug-resistant ecthyma gangrenosum in a neutropenic patient with acute myeloid leukemia. We emphasize the importance of leukopenia resolution for recovery, which is often not achieved in prolonged neutropenic patients.

Infectious Diseases in Clinical PracticeVol. 33(3)
University of South Florida (US), Moffitt Cancer Center (US)
Openalex Percentile: Top 95%
Infections and bacterial resistance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Ecthyma Gangrenosum of the Groin Resistant to Ciprofloxacin, Cefepime, Metronidazole, and Meropenem. What's Next? — Nicole Natarelli, Sadaf Aslam, et al. · Infectious Diseases in Clinical Practice (2025) | TGRS Research Map | TGRS